Cite Filings / FATE / 0001193125-26-450034

Feed Companies Filings Check

Sign in

S-3

Registration Statement

FATE THERAPEUTICS INC Filed 2026-11-05 Acc 0001193125-26-450034

Documents 1

S-3 Registration Statement , d150438ds3.htm

Around this filing

2026-11-05 S-3 Registration Statement
2026-11-05 424B5 Prospectus
2026-11-05 8-K Material agreement · Agreement ended
2026-11-05 10-Q Quarterly Report
2026-11-05 8-K Results of operations
2026-11-04 4 Chief Financial Officer sold 6,582 shares at $2.05 ($13,525)
2024-04-18 S-3 Registration Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading d150438ds3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…